Larsson L E, Melin P, Ragnarsson U
Int J Pept Protein Res. 1976;8(1):39-44.
A convenient scheme for the synthesis of 4,8-disubstituted vasopressins has been designed and its usefulness evaluated in the preparation of one of the parent hormones, 8-arginine-vasopressin. The main feature of the scheme involves preparation of two protected tripeptide fragments, Z-Cys(Bzl)-Tyr(Bzl)-Phe and Boc-Asn(Mbh)-Cys(Bzl)-Pro which are incorporated in a synthesis on a solid support. Both tripeptides were prepared conventionally with the carboxyl groups protected as benzyl esters. The benzyl-ester groups were removed by transesterification with 2-dimethylaminoethanol and subsequent hydrolysis. To avoid racemization in the coupling step with the fragment containing a C-terminal phenylalanine, N-hydroxysuccinimide was added. After removal of the peptide from the resin, deprotection, oxidation and desalting, final purification was effected by ion-exchange chromatography. Apart from the main product, which exhibited full pressor activity, only small amounts of impurities could be isolated.
设计了一种合成4,8-二取代血管加压素的简便方案,并在制备母体激素之一8-精氨酸血管加压素中评估了其有效性。该方案的主要特点包括制备两个受保护的三肽片段,即Z-Cys(Bzl)-Tyr(Bzl)-Phe和Boc-Asn(Mbh)-Cys(Bzl)-Pro,它们在固相载体合成中结合。两种三肽均按常规方法制备,羧基被保护为苄酯。通过与2-二甲基氨基乙醇进行酯交换并随后水解来除去苄酯基团。为避免在与含有C端苯丙氨酸的片段偶联步骤中发生消旋,加入了N-羟基琥珀酰亚胺。从树脂上除去肽后,进行脱保护、氧化和脱盐,最后通过离子交换色谱法进行纯化。除了具有完全升压活性的主要产物外,仅能分离出少量杂质。